These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 7840829

  • 41. Association of p53 tumor suppressor gene with paraclinical and clinical modalities of gliomas patients in Malaysia.
    Yusoff AA, Abdullah J, Abdullah MR, Mohd Ariff AR, Isa MN.
    Acta Neurochir (Wien); 2004 Jun; 146(6):595-601. PubMed ID: 15168228
    [Abstract] [Full Text] [Related]

  • 42. [Tumor suppressor gene p53. Theoretical principles and their significance for pathology].
    Poremba C, Bankfalvi A, Dockhorn-Dworniczak B.
    Pathologe; 1996 May; 17(3):181-8. PubMed ID: 8710788
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. The p53 gene and protein in human brain tumors.
    Louis DN.
    J Neuropathol Exp Neurol; 1994 Jan; 53(1):11-21. PubMed ID: 8301315
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Mutation of the p53 gene in human astrocytic tumours correlates with increased resistance to DNA-damaging agents but not to anti-microtubule anti-cancer agents.
    Iwadate Y, Tagawa M, Fujimoto S, Hirose M, Namba H, Sueyoshi K, Sakiyama S, Yamaura A.
    Br J Cancer; 1998 Feb; 77(4):547-51. PubMed ID: 9484809
    [Abstract] [Full Text] [Related]

  • 48. P53 gene mutations: case study of a clinical marker for solid tumors.
    Liu MC, Gelmann EP.
    Semin Oncol; 2002 Jun; 29(3):246-57. PubMed ID: 12063677
    [Abstract] [Full Text] [Related]

  • 49. Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations.
    Nordsmark M, Alsner J, Keller J, Nielsen OS, Jensen OM, Horsman MR, Overgaard J.
    Br J Cancer; 2001 Apr 20; 84(8):1070-5. PubMed ID: 11308256
    [Abstract] [Full Text] [Related]

  • 50. William L. McGuire Memorial Symposium. The role and prognostic significance of p53 gene alterations in breast cancer.
    Elledge RM, Fuqua SA, Clark GM, Pujol P, Allred DC.
    Breast Cancer Res Treat; 1993 Apr 20; 27(1-2):95-102. PubMed ID: 8260732
    [Abstract] [Full Text] [Related]

  • 51. Cancer progression and p53.
    Carson DA, Lois A.
    Lancet; 1995 Oct 14; 346(8981):1009-11. PubMed ID: 7475551
    [Abstract] [Full Text] [Related]

  • 52. Redefining p53--entering the tumor suppressor era.
    Baker SJ.
    Cell Cycle; 2003 Oct 14; 2(1):7-8. PubMed ID: 12695673
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. The importance of genome architecture in cancer susceptibility: location, location, location.
    Reilly KM.
    Cell Cycle; 2004 Nov 14; 3(11):1378-82. PubMed ID: 15492507
    [Abstract] [Full Text] [Related]

  • 56. Role of Mycoplasma Chaperone DnaK in Cellular Transformation.
    Benedetti F, Cocchi F, Latinovic OS, Curreli S, Krishnan S, Munawwar A, Gallo RC, Zella D.
    Int J Mol Sci; 2020 Feb 15; 21(4):. PubMed ID: 32075244
    [Abstract] [Full Text] [Related]

  • 57. The influence of cell context on the selection pressure for p53 mutation in human cancer.
    Wynford-Thomas D, Blaydes J.
    Carcinogenesis; 1998 Jan 15; 19(1):29-36. PubMed ID: 9472689
    [Abstract] [Full Text] [Related]

  • 58. BRCA1 has a pivotal role in repairing DNA.
    Frankish H.
    Lancet; 2001 May 26; 357(9269):1678. PubMed ID: 11425380
    [No Abstract] [Full Text] [Related]

  • 59. The clinical significance of p53 aberrations in human tumours.
    Bosari S, Viale G.
    Virchows Arch; 1995 May 26; 427(3):229-41. PubMed ID: 7496591
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.